Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Esserman

Showing results (91-100 of 143) with videos related to

Pageof 15
Sort By:
International Journal of Radiation Oncology, Biology, Physics|July 22, 2015
In Regard to Hepel and WazerJayant S Vaidya, Max Bulsara, Frederik Wenz, et al.
Journal of Pain and Symptom Management|December 21, 2014
Preoperative Breast Pain Predicts Persistent Breast Pain and Disability After Breast Cancer SurgeryDale J Langford, Brian Schmidt, Jon D Levine, et al.
International Journal of Radiation Oncology, Biology, Physics|June 13, 2015
Pride, Prejudice, or Science: Attitudes Towards the Results of the TARGIT-A Trial of Targeted Intraoperative Radiation Therapy for Breast CancerJayant S Vaidya, Max Bulsara, Frederik Wenz, et al.
JAMA|February 15, 2017
Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast CancerHope S Rugo, Paula Klein, Susan Anitra Melin, et al.
Breast Cancer Research : BCR|May 30, 2015
Serial expression analysis of breast tumors during neoadjuvant chemotherapy reveals changes in cell cycle and immune pathways associated with recurrence and responseMark Jesus M Magbanua, Denise M Wolf, Christina Yau, et al.
Journal of Medical Imaging (Bellingham, Wash.)|January 4, 2018
Features of MRI stromal enhancement with neoadjuvant chemotherapy: a subgroup analysis of the ACRIN 6657/I-SPY TRIALAdam Olshen, Denise Wolf, Ella F Jones, et al.
Breast Cancer Research and Treatment|June 4, 2017
Comparison of residual cancer burden, American Joint Committee on Cancer staging and pathologic complete response in breast cancer after neoadjuvant chemotherapy: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)Jeffrey I Campbell, Christina Yau, Polina Krass, et al.
Journal of the National Cancer Institute|September 24, 2010
Long-term prognostic role of functional limitations among women with breast cancerDejana Braithwaite, William A Satariano, Barbara Sternfeld, et al.
Frontiers in Oncology|June 29, 2023
Computational drug repositioning for the identification of new agents to sensitize drug-resistant breast tumors across treatments and receptor subtypesKatharine Yu, Amrita Basu, Christina Yau, et al.
Research Square|May 20, 2024
Tumor microenvironmental determinants of high-risk DCIS progressionAlexander Borowsky, Alexa Glencer, Kirithiga Ramalingam, et al.
Pageof 15

Showing results (91-100 of 143) with videos related to

Sort By:
Pageof 15
International Journal of Radiation Oncology, Biology, Physics|July 22, 2015
In Regard to Hepel and WazerJayant S Vaidya, Max Bulsara, Frederik Wenz, et al.
Journal of Pain and Symptom Management|December 21, 2014
Preoperative Breast Pain Predicts Persistent Breast Pain and Disability After Breast Cancer SurgeryDale J Langford, Brian Schmidt, Jon D Levine, et al.
International Journal of Radiation Oncology, Biology, Physics|June 13, 2015
Pride, Prejudice, or Science: Attitudes Towards the Results of the TARGIT-A Trial of Targeted Intraoperative Radiation Therapy for Breast CancerJayant S Vaidya, Max Bulsara, Frederik Wenz, et al.
JAMA|February 15, 2017
Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast CancerHope S Rugo, Paula Klein, Susan Anitra Melin, et al.
Breast Cancer Research : BCR|May 30, 2015
Serial expression analysis of breast tumors during neoadjuvant chemotherapy reveals changes in cell cycle and immune pathways associated with recurrence and responseMark Jesus M Magbanua, Denise M Wolf, Christina Yau, et al.
Journal of Medical Imaging (Bellingham, Wash.)|January 4, 2018
Features of MRI stromal enhancement with neoadjuvant chemotherapy: a subgroup analysis of the ACRIN 6657/I-SPY TRIALAdam Olshen, Denise Wolf, Ella F Jones, et al.
Breast Cancer Research and Treatment|June 4, 2017
Comparison of residual cancer burden, American Joint Committee on Cancer staging and pathologic complete response in breast cancer after neoadjuvant chemotherapy: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)Jeffrey I Campbell, Christina Yau, Polina Krass, et al.
Journal of the National Cancer Institute|September 24, 2010
Long-term prognostic role of functional limitations among women with breast cancerDejana Braithwaite, William A Satariano, Barbara Sternfeld, et al.
Frontiers in Oncology|June 29, 2023
Computational drug repositioning for the identification of new agents to sensitize drug-resistant breast tumors across treatments and receptor subtypesKatharine Yu, Amrita Basu, Christina Yau, et al.
Research Square|May 20, 2024
Tumor microenvironmental determinants of high-risk DCIS progressionAlexander Borowsky, Alexa Glencer, Kirithiga Ramalingam, et al.
Pageof 15